Wetzel Investment Advisors, Inc. Chemomab Therapeutics Ltd. Transaction History
Wetzel Investment Advisors, Inc.
- $196 Million
- Q4 2024
A detailed history of Wetzel Investment Advisors, Inc. transactions in Chemomab Therapeutics Ltd. stock. As of the latest transaction made, Wetzel Investment Advisors, Inc. holds 10,000 shares of CMMB stock, worth $21,400. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$21,400% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding CMMB
# of Institutions
19Shares Held
4.57MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA1.74MShares$3.73 Million0.06% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L31.21MShares$2.6 Million0.35% of portfolio
-
Yelin Lapidot Holdings Management Ltd. Tel Aviv, L3810KShares$1.73 Million0.21% of portfolio
-
Morgan Stanley New York, NY402KShares$860,8620.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX213KShares$456,6580.06% of portfolio
About Chemomab Therapeutics Ltd.
- Ticker CMMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,431,700
- Market Cap $24.5M
- Description
- Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (...